Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
120 participants
INTERVENTIONAL
2020-05-13
2024-05-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Spasticity and Functional Recovery After SCI
NCT06030531
Neural Facilitation of Movements in People With SCI
NCT05354206
Influence of Wearable Intensive Nerve Stimulation on Spasticity and Function in Persons With Spinal Cord Injury
NCT04130295
Spinal Cord Stimulation to Augment Activity Based Therapy
NCT03240601
Extracorporeal Shockwave Therapy for Spasticity in People With Spinal Cord Injury
NCT05432999
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In Aim 1, we will use transcranial magnetic stimulation and startle acoustic stimuli to examine the contribution of the cortico- and reticulo-spinal pathway to upper and/or lower limb muscles electromyographic activity. Spinal cord atrophy and morphological characterization of cortico- and reticulo-spinal pathways will be assessed with high-resolution magnetic resonance imaging. Physiological and neuroimaging outcomes will be associated with clinical assessment of spasticity.
In Aim 2, we propose to enhance cortico- and reticulo-spinal contribution to upper and/or lower limb function in spastic muscles by using a novel intervention combining startle acoustic stimuli with motor training.
This research will provide new knowledge about the contribution of descending motor pathways to the control of spasticity in upper and lower limb muscles following incomplete cervical SCI (Aim1) and might lead to the development of a novel rehabilitation intervention to improve upper and lower limb motor function recovery by enhancing residual descending control over spinal networks (Aim 2).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Aim 1
To accomplish this aim, we will conduct one experiment in two sessions separated by 2- 3 days using a crossover design. Participants will be assigned into one of three groups: spastic SCI, non-spastic SCI, and controls. We expect that people enrolled in Aim 1 will complete 2 visits within 1 week.
Visit 1 Measurements:
* MVCs
* MEP Recruitment Curves
* iMEPs
* StartReact
Visit 2 Measurements:
* Participant Reported Spasticity
* MAS
* PSAD
* KINARM
* MRI of brain and spinal cord
Acoustic stimuli (Startle)
A startle stimulus (120 dB, 500 Hz, 50 ms) will be delivered through headphones
Aim 2
To accomplish this aim, we will use a randomized crossover design study with spastic SCI participants receiving a single intervention combining non-invasive acoustic stimuli (Startle) or sham-Startle with motor training to enhance cortico- and reticulo-spinal contribution, separated by \~2 weeks.
Visit 1 and Visit 2
Single intervention of:
Startle + exercise training OR sham-Startle + exercise training
Pre and post measurements:
* MVCs
* MEP recruitment curves
* iMEPs
* StartReact
* Participant reported spasticity
* MAS
* PSAD
* KINARM
* Neuromechanical hand and/or leg testing
* GRASSP
* TRI-HFT
* 10-meter walk test
* Pendulum Test
Acoustic stimuli (Startle)
A startle stimulus (120 dB, 500 Hz, 50 ms) will be delivered through headphones
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acoustic stimuli (Startle)
A startle stimulus (120 dB, 500 Hz, 50 ms) will be delivered through headphones
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Incomplete spinal cord injury at T12 or above
* Males and Females
* Ages 18-75 years
-MAS scores of 0 and 1
* MAS scores of 2, 3 and 4
* The ability to perform a voluntary flexion and extension of the elbow and/or knee or ankle
* The ability to reach and grasp an object
* Males and females
* Ages 18-75 years
* Right-handed
* Able to perform elbow and/or knee or ankle flexion and extension
Exclusion Criteria
* Any debilitating disease prior to the SCI that caused exercise intolerance
* Premorbid, ongoing major depression or psychosis, altered cognitive status
* History of head injury or stroke
* Pacemaker
* Metal plate in skull
* History of seizures
* Receiving drugs acting primarily on the central nervous system, which lower the seizure threshold such as antipsychotic drugs (chlorpromazine, clozapine) or tricyclic antidepressants
* Pregnant females
* Ongoing cord compression or a syrinx in the spinal cord or who suffer from a spinal cord disease such as spinal stenosis, spina bifida, or herniated cervical disk
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shirley Ryan AbilityLab
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Monica Perez
Scientific Chair Arms + Hands Lab
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shirley Ryan AbilityLab
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU00212201
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.